The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
Abstract Background The presence of circulating cell-free DNA from tumours in blood (ctDNA) is of major importance to those interested in early cancer detection, as well as to those wishing to monitor tumour progression or diagnose the presence of activating mutations to guide treatment. In 2014, th...
Main Authors: | Ian A. Cree, Lesley Uttley, Helen Buckley Woods, Hugh Kikuchi, Anne Reiman, Susan Harnan, Becky L. Whiteman, Sian Taylor Philips, Michael Messenger, Angela Cox, Dawn Teare, Orla Sheils, Jacqui Shaw, For the UK Early Cancer Detection Consortium |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-017-3693-7 |
Similar Items
-
MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis
by: Sadakatsu Ikeda, et al.
Published: (2018-06-01) -
International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
by: Cleo Keppens, et al.
Published: (2018-08-01) -
Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma
by: Yuyuan Zhang, et al.
Published: (2021-09-01) -
Extracellular Vesicle-Derived DNA vs. CfDNA as a Biomarker for the Detection of Colon Cancer
by: Kavita Thakur, et al.
Published: (2021-07-01) -
Tekočinska biopsija pri raku
by: Tanja Jesenko, et al.
Published: (2018-09-01)